GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
Europe - OSL:GENT - NO0010748866 - Common Stock
55 NOK
-0.2 (-0.36%)
GENT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. GENT has an excellent financial health rating, but there are some minor concerns on its profitability. GENT is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year GENT was profitable.
In the past year GENT had a positive cash flow from operations.
GENT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
With an excellent Return On Assets value of 18.25%, GENT belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
GENT's Return On Equity of 21.37% is amongst the best of the industry. GENT outperforms 88.33% of its industry peers.
GENT has a Return On Invested Capital of 7.59%. This is in the better half of the industry: GENT outperforms 63.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROIC | 7.59% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GENT has a Profit Margin of 25.83%. This is amongst the best in the industry. GENT outperforms 93.33% of its industry peers.
GENT's Operating Margin of 12.10% is in line compared to the rest of the industry. GENT outperforms 56.67% of its industry peers.
GENT's Gross Margin of 54.19% is in line compared to the rest of the industry. GENT outperforms 46.67% of its industry peers.
In the last couple of years the Gross Margin of GENT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
GENT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GENT has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for GENT remains at a similar level compared to 5 years ago.
The debt/assets ratio for GENT has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 16.10 indicates that GENT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 16.10, GENT belongs to the best of the industry, outperforming 96.67% of the companies in the same industry.
The Debt to FCF ratio of GENT is 0.33, which is an excellent value as it means it would take GENT, only 0.33 years of fcf income to pay off all of its debts.
GENT has a better Debt to FCF ratio (0.33) than 91.67% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that GENT is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.02, GENT belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Altman-Z | 16.1 |
ROIC/WACC0.89
WACC8.51%
2.3 Liquidity
A Current Ratio of 5.47 indicates that GENT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.47, GENT belongs to the top of the industry, outperforming 98.33% of the companies in the same industry.
A Quick Ratio of 3.78 indicates that GENT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.78, GENT belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 |
3. Growth
3.1 Past
GENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2103.43%, which is quite impressive.
The Revenue has grown by 11.68% in the past year. This is quite good.
Measured over the past years, GENT shows a very strong growth in Revenue. The Revenue has been growing by 25.96% on average per year.
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
3.2 Future
The Earnings Per Share is expected to grow by 62.29% on average over the next years. This is a very strong growth
Based on estimates for the next years, GENT will show a very strong growth in Revenue. The Revenue will grow by 31.72% on average per year.
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 20.45 indicates a rather expensive valuation of GENT.
Compared to the rest of the industry, the Price/Earnings ratio of GENT indicates a somewhat cheap valuation: GENT is cheaper than 78.33% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.51. GENT is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 20.27 indicates a rather expensive valuation of GENT.
Based on the Price/Forward Earnings ratio, GENT is valued a bit cheaper than the industry average as 65.00% of the companies are valued more expensively.
GENT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.53, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.45 | ||
| Fwd PE | 20.27 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GENT is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
GENT's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 89.6 | ||
| EV/EBITDA | 26.88 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GENT's earnings are expected to grow with 62.29% in the coming years.
PEG (NY)0.34
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
GENT has a yearly dividend return of 0.70%, which is pretty low.
Compared to an average industry Dividend Yield of 2.13, GENT has a dividend in line with its industry peers.
With a Dividend Yield of 0.70, GENT pays less dividend than the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.7% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
OSL:GENT (11/3/2025, 7:00:00 PM)
55
-0.2 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.83%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap848.10M
Revenue(TTM)163.38M
Net Income(TTM)42.19M
Analysts85.71
Price Target68.34 (24.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.7% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.45 | ||
| Fwd PE | 20.27 | ||
| P/S | 5.19 | ||
| P/FCF | 89.6 | ||
| P/OCF | 42.63 | ||
| P/B | 4.3 | ||
| P/tB | 5.11 | ||
| EV/EBITDA | 26.88 |
EPS(TTM)2.69
EY4.89%
EPS(NY)2.71
Fwd EY4.93%
FCF(TTM)0.61
FCFY1.12%
OCF(TTM)1.29
OCFY2.35%
SpS10.6
BVpS12.81
TBVpS10.76
PEG (NY)0.34
PEG (5Y)N/A
Graham Number27.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROCE | 9.86% | ||
| ROIC | 7.59% | ||
| ROICexc | 12.65% | ||
| ROICexgc | 17.14% | ||
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% | ||
| FCFM | 5.79% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | 115.57% | ||
| Cap/Sales | 6.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 69.08% | ||
| Profit Quality | 22.43% | ||
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 | ||
| Altman-Z | 16.1 |
F-Score5
WACC8.51%
ROIC/WACC0.89
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1114.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y257.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8223.43%
OCF growth 3YN/A
OCF growth 5YN/A
GENTIAN DIAGNOSTICS ASA / GENT.OL FAQ
Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?
ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.
What is the valuation status of GENTIAN DIAGNOSTICS ASA (GENT.OL) stock?
ChartMill assigns a valuation rating of 4 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.
Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?
GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for GENT stock?
The Price/Earnings (PE) ratio for GENTIAN DIAGNOSTICS ASA (GENT.OL) is 20.45 and the Price/Book (PB) ratio is 4.3.